Stanford University
Showing 441-450 of 473 Results
-
Chao-Lin Kuo
Professor of Physics and of Particle Physics and Astrophysics
Current Research and Scholarly Interests1. Searching/measuring primordial gravitational waves in the CMB (Cosmic Microwave Background) through experiments at the South Pole (BICEP and SPT), high plateaus in Tibet (AliCPT) and Atacama (Simons Observatory), as well as in space (LiteBIRD).
2. Development and applications of superconducting detector and readout systems in astrophysics, cosmology, and other areas.
3. Novel detector concepts for axion searches (https://youtu.be/UBscQSFzpLE) -
WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE
Professor of Radiology (Interventional Radiology)
On Leave from 07/01/2024 To 07/31/2024Current Research and Scholarly Interests1) LASER-ASSISTED AND COMPLEX IVC FILTER RETRIEVAL
2) CATHETER-DIRECTED THERAPY FOR ACUTE PULMONARY EMBOLISM
3) INTERNATIONAL PE REGISTRY
4) IVC FILTER REGISTRY
5) ENDOVASCULAR TREATMENT OF CAVAL AND DEEP VENOUS THROMBOSIS -
Clair Mariam Kuriakose
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioClair Kuriakose is a Physician Assistant with a clinical background in Pediatric Surgery. She joined Stanford September 2014 as the first Manager of Advanced Practice with the Center for Advanced Practice and officially transitioned to the Executive Director of Advanced Practice on August 2017. Clair is passionate about the value advanced practice providers bring to the complex and ever-changing healthcare industry and truly enjoys collaborating with the various Advanced Practice Providers in the organization to ensure the best care for our patients.
-
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.